Author: Eli Patterson

Whitepaper: Philips Respironics’ DreamMapper

Treatment with PAP therapy is effective, but adherence to treatment is poor. Lower adherence can result in undertreated patients and, in some cases, may lead to refusal of insurers to pay for therapy. DreamMapper is a mobile application and website that employs theoretically driven and empirically tested interventions designed to improve adherence to PAP therapy.

Read More

Digital Edition Archive

Jun/Jul 2019 May 2019 Mar/Apr 2019 2019 Buyer’s Guide January 2019 Nov/Dec 2018 Additional Issues October 2018 Aug/Sep Jun/Jul 2018 May 2018 April 2018 2018 Buyer’s Guide January 2018 Nov/Dec 2017 October 2017...

Read More
  • 1
  • 2